Back to Anacor Homepage Developing Drug Candidates Through Boron Chemistry
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.
Overview | Press Releases | Publications | Contact Us | Scientific Presentations
  News and Events Overview

The newsroom is designed to provide easy access to Anacor news and information. For media inquiries please email: media@anacor.com.



We are a biopharmaceutical company developing small molecule therapeutics derived from our boron chemistry platform Learn more about Tavaborole
Learn more about AN2728
Learn more about GSK 052